Arca
Skip to content
Tools
Tools

-imod

Drugs that adjust the immune response.

  • Drugs ending in -imod: 69
  • Approved somewhere: 7
  • With a US drug page: 6

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-imod
Class
Drugs that adjust the immune response
Sub-stems
-mapimod, -tolimod
Most common targets
MAPK14 (8), S1PR1 (6), TLR9 (5), TLR7 (4), TLR8 (4), Sphingosine 1-phosphate receptor (2), S1PR5 (2), FCGRT (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -imod or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
Efgartigimod alfaApprovedFCGRTIgG receptor FcRn large subunit p51 antagonist
FingolimodApprovedSphingosine 1-phosphate receptorSphingosine 1-phosphate receptor agonist
ImiquimodApprovedTLR7Toll-like receptor 7 agonist
OzanimodApprovedS1PR1, S1PR5Sphingosine 1-phosphate receptor Edg-1 modulator
PonesimodApprovedS1PR1Sphingosine 1-phosphate receptor Edg-1 agonist
SiponimodApprovedS1PR1Sphingosine 1-phosphate receptor Edg-1 agonist
EtrasimodApprovedS1PR1, S1PR4, S1PR5Sphingosine 1-phosphate receptor Edg-1 agonist
BlisibimodPhase 3TNFSF13BTumor necrosis factor ligand superfamily member 13B inhibitor
CenerimodPhase 3S1PR1Sphingosine 1-phosphate receptor Edg-1 modulator
ForigerimodPhase 3HSPA8Heat shock cognate 71 kDa protein inhibitor
IguratimodPhase 3MIF, TRAF3IP2, PTGS2Macrophage migration inhibitory factor inhibitor
LaquinimodPhase 3——
ObefazimodPhase 3NCBP1, NCBP2Cap binding complex modulator
TasquinimodPhase 3——
AmiselimodPhase 2Sphingosine 1-phosphate receptorSphingosine 1-phosphate receptor modulator
AmlisimodPhase 2——
ApilimodPhase 2PIKFYVE1-phosphatidylinositol 3-phosphate 5-kinase inhibitor
AtiprimodPhase 2——
CridanimodPhase 2——
EpetirimodPhase 2——
GolotimodPhase 2——
IcanbelimodPhase 2——
IndoximodPhase 2mTORC1mTORC1 activator
LimaresiquimodPhase 2——
LirodegimodPhase 2——
MocravimodPhase 2S1PR1Sphingosine 1-phosphate receptor Edg-1 agonist
MosedipimodPhase 2——
OrilotimodPhase 2——
PaquinimodPhase 2——
PidotimodPhase 2——
ReltecimodPhase 2——
ResiquimodPhase 2TLR8, TLR7Toll-like receptor 8 agonist
TamuzimodPhase 2——
VonifimodPhase 2——
AlintegimodPhase 1——
BevifimodPhase 1——
DefoslimodPhase 1——
Efizonerimod alfaPhase 1——
Eftilagimod alfaPhase 1LAG3Lymphocyte activation gene 3 protein vaccine antigen
NavoximodPhase 1——
UdifitimodPhase 1——
LosmapimodPhase 3MAPK14, MAPK11MAP kinase p38 alpha inhibitor
AcumapimodPhase 2MAPK14MAP kinase p38 alpha inhibitor
BentamapimodPhase 2c-Jun N-terminal kinase, JNKc-Jun N-terminal kinase, JNK inhibitor
DilmapimodPhase 2MAPK14MAP kinase p38 alpha inhibitor
DoramapimodPhase 2MAPK14MAP kinase p38 alpha inhibitor
NeflamapimodPhase 2MAPK14MAP kinase p38 alpha inhibitor
SemapimodPhase 2MAPK14MAP kinase p38 alpha inhibitor
TalmapimodPhase 2MAPK14MAP kinase p38 alpha inhibitor
EmprumapimodPhase 1——
Balamapimod—MAP2K1, MAP2K2Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Pamapimod—MAPK14MAP kinase p38 alpha inhibitor
AgatolimodPhase 3TLR9Toll-like receptor 9 agonist
CobitolimodPhase 3TLR9Toll-like receptor 9 agonist
RintatolimodPhase 3TLR3Toll-like receptor 3 agonist
TilsotolimodPhase 3TLR9Toll-like receptor 9 agonist
EntolimodPhase 2TLR5Toll-like receptor 5 agonist
LefitolimodPhase 2TLR9Toll-like receptor 9 agonist
MotolimodPhase 2TLR8Toll-like receptor 8 agonist
RuzotolimodPhase 2——
SelgantolimodPhase 2TLR8Toll-like receptor 8 agonist
Tilsotolimod sodiumPhase 2TLR9Toll-like receptor 9 agonist
VesatolimodPhase 2TLR7Toll-like receptor 7 activator
VidutolimodPhase 2——
Cobitolimod sodiumPhase 1——
GuretolimodPhase 1——
NelitolimodPhase 1——
Nelitolimod sodiumPhase 1——
TelratolimodPhase 1TLR8, TLR7Toll-like receptor 8 agonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.